Back to Search
PHILIP SAGER, MD
MD
Cardiovascular Disease Physician
NPI: 1427487149Individual
Specialties, Licenses & Credentials
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
G62729(CA)
Research & Publications (20)
Key clinical considerations for demonstrating the utility of preclinical models to predict clinical drug-induced torsades de pointes.
PMID 18536754·Br J Pharmacol·2008
6-review
Rapid conversion of persistent atrial fibrillation to sinus rhythm by intravenous AZD7009.
PMID 19129422·J Clin Pharmacol·2009
4-observational
Preventing tomorrow's sudden cardiac death today: dissemination of effective therapies for sudden cardiac death prevention.
PMID 18926144·Am Heart J·2008
8-other
International Life Sciences Institute (Health and Environmental Sciences Institute, HESI) initiative on moving towards better predictors of drug-induced torsades de pointes.
PMID 18663380·Br J Pharmacol·2008
7-preclinical
Early clinical development: evaluation of drug-induced torsades de pointes risk.
PMID 18601950·Pharmacol Ther·2008
8-other
Moving towards better predictors of drug-induced torsades de pointes.
PMID 18574462·Br J Pharmacol·2008
7-preclinical
QT/QTc prolongation in placebo-treated subjects: a PhRMA collaborative data analysis.
PMID 18470753·J Biopharm Stat·2008
8-other
A prototypical process for creating evidentiary standards for biomarkers and diagnostics.
PMID 18091762·Clin Pharmacol Ther·2008
7-preclinical
Long-term efficacy and safety of rosuvastatin 40 mg in patients with severe hypercholesterolemia.
PMID 17950795·Am J Cardiol·2007
4-observational
Comparison of effectiveness of rosuvastatin versus atorvastatin on the achievement of combined C-reactive protein (<2 mg/L) and low-density lipoprotein cholesterol (< 70 mg/dl) targets in patients with type 2 diabetes mellitus (from the ANDROMEDA study).
PMID 17920365·Am J Cardiol·2007
3-trial
Effect of short-term rosuvastatin treatment on estimated glomerular filtration rate.
PMID 16728222·Am J Cardiol·2006
4-observational
Clinical evaluation of QT/QTc prolongation and proarrhythmic potential for nonantiarrhythmic drugs: the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use E14 guideline.
PMID 16638733·J Clin Pharmacol·2006
6-review
Comparison of efficacy and safety of rosuvastatin versus atorvastatin in African-American patients in a six-week trial.
PMID 16442368·Am J Cardiol·2006
4-observational
Effect of rosuvastatin or atorvastatin on urinary albumin excretion and renal function in type 2 diabetic patients.
PMID 16246447·Diabetes Res Clin Pract·2006
4-observational
Comparison of ezetimibe plus simvastatin versus simvastatin monotherapy on atherosclerosis progression in familial hypercholesterolemia. Design and rationale of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression (ENHANCE) trial.
PMID 15846260·Am Heart J·2005
8-other
Effects of ezetimibe coadministered with simvastatin on C-reactive protein in a large cohort of hypercholesterolemic patients.
PMID 15777554·Atherosclerosis·2005
3-trial
Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
PMID 15650343·J Womens Health (Larchmt)·2004
4-observational
Efficacy and safety of coadministration of ezetimibe and statins in elderly patients with primary hypercholesterolaemia.
PMID 15631531·Drugs Aging·2004
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 719 CAROLINA ST
SAN FRANCISCO, CA 94107 - Phone
- (650) 450-7477
Quick Facts
- NPI
- 1427487149
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile